Logo image of CRD.B

CRAWFORD & CO -CL B (CRD.B) Stock Fundamental Analysis

NYSE:CRD.B - New York Stock Exchange, Inc. - US2246331076 - Common Stock - Currency: USD

10.2  -0.53 (-4.94%)

After market: 9.83 -0.37 (-3.63%)

Fundamental Rating

5

CRD.B gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 144 industry peers in the Insurance industry. While CRD.B has a great profitability rating, there are some minor concerns on its financial health. CRD.B has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CRD.B was profitable.
CRD.B had a positive operating cash flow in the past year.
CRD.B had positive earnings in 4 of the past 5 years.
CRD.B had a positive operating cash flow in each of the past 5 years.
CRD.B Yearly Net Income VS EBIT VS OCF VS FCFCRD.B Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

CRD.B has a better Return On Assets (3.84%) than 79.86% of its industry peers.
With an excellent Return On Equity value of 18.96%, CRD.B belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
CRD.B has a Return On Invested Capital of 8.08%. This is amongst the best in the industry. CRD.B outperforms 91.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRD.B is above the industry average of 4.08%.
The 3 year average ROIC (7.40%) for CRD.B is below the current ROIC(8.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.84%
ROE 18.96%
ROIC 8.08%
ROA(3y)1.61%
ROA(5y)2.44%
ROE(3y)7.94%
ROE(5y)10.69%
ROIC(3y)7.4%
ROIC(5y)7.11%
CRD.B Yearly ROA, ROE, ROICCRD.B Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With a Profit Margin value of 2.25%, CRD.B is not doing good in the industry: 75.69% of the companies in the same industry are doing better.
CRD.B's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 4.72%, CRD.B is doing worse than 78.47% of the companies in the same industry.
CRD.B's Operating Margin has declined in the last couple of years.
The Gross Margin of CRD.B (27.41%) is better than 89.58% of its industry peers.
CRD.B's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.72%
PM (TTM) 2.25%
GM 27.41%
OM growth 3Y-0.78%
OM growth 5Y-6.8%
PM growth 3Y-9.71%
PM growth 5Y10.7%
GM growth 3Y2.28%
GM growth 5Y-0.53%
CRD.B Yearly Profit, Operating, Gross MarginsCRD.B Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRD.B is destroying value.
The number of shares outstanding for CRD.B has been increased compared to 1 year ago.
Compared to 5 years ago, CRD.B has less shares outstanding
Compared to 1 year ago, CRD.B has a worse debt to assets ratio.
CRD.B Yearly Shares OutstandingCRD.B Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRD.B Yearly Total Debt VS Total AssetsCRD.B Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

CRD.B has an Altman-Z score of 3.03. This indicates that CRD.B is financially healthy and has little risk of bankruptcy at the moment.
CRD.B's Altman-Z score of 3.03 is amongst the best of the industry. CRD.B outperforms 94.44% of its industry peers.
The Debt to FCF ratio of CRD.B is 15.33, which is on the high side as it means it would take CRD.B, 15.33 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 15.33, CRD.B is doing worse than 75.69% of the companies in the same industry.
CRD.B has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
CRD.B has a worse Debt to Equity ratio (1.28) than 88.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 15.33
Altman-Z 3.03
ROIC/WACC0.86
WACC9.4%
CRD.B Yearly LT Debt VS Equity VS FCFCRD.B Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

CRD.B has a Current Ratio of 1.30. This is a normal value and indicates that CRD.B is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.30, CRD.B belongs to the best of the industry, outperforming 86.11% of the companies in the same industry.
CRD.B has a Quick Ratio of 1.30. This is a normal value and indicates that CRD.B is financially healthy and should not expect problems in meeting its short term obligations.
CRD.B has a better Quick ratio (1.30) than 86.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.3
CRD.B Yearly Current Assets VS Current LiabilitesCRD.B Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.54% over the past year.
CRD.B shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.30% yearly.
Looking at the last year, CRD.B shows a small growth in Revenue. The Revenue has grown by 3.51% in the last year.
Measured over the past years, CRD.B shows a small growth in Revenue. The Revenue has been growing by 5.06% on average per year.
EPS 1Y (TTM)11.54%
EPS 3Y2.67%
EPS 5Y4.3%
EPS Q2Q%61.54%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y5.59%
Revenue growth 5Y5.06%
Sales Q2Q%-0.33%

3.2 Future

CRD.B is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.76% yearly.
Based on estimates for the next years, CRD.B will show a small growth in Revenue. The Revenue will grow by 5.91% on average per year.
EPS Next Y32.55%
EPS Next 2Y19.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.49%
Revenue Next 2Y5.91%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CRD.B Yearly Revenue VS EstimatesCRD.B Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
CRD.B Yearly EPS VS EstimatesCRD.B Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.72, the valuation of CRD.B can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of CRD.B is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CRD.B to the average of the S&P500 Index (26.69), we can say CRD.B is valued rather cheaply.
A Price/Forward Earnings ratio of 9.00 indicates a reasonable valuation of CRD.B.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRD.B is on the same level as its industry peers.
CRD.B's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.29.
Industry RankSector Rank
PE 11.72
Fwd PE 9
CRD.B Price Earnings VS Forward Price EarningsCRD.B Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRD.B is valued a bit cheaper than 68.75% of the companies in the same industry.
73.61% of the companies in the same industry are cheaper than CRD.B, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 31.37
EV/EBITDA 7.18
CRD.B Per share dataCRD.B EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

CRD.B's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRD.B has a very decent profitability rating, which may justify a higher PE ratio.
CRD.B's earnings are expected to grow with 19.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.36
PEG (5Y)2.73
EPS Next 2Y19.76%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

CRD.B has a Yearly Dividend Yield of 2.79%. Purely for dividend investing, there may be better candidates out there.
CRD.B's Dividend Yield is a higher than the industry average which is at 3.52.
Compared to an average S&P500 Dividend Yield of 2.43, CRD.B has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.79%

5.2 History

The dividend of CRD.B has a limited annual growth rate of 2.90%.
CRD.B has paid a dividend for at least 10 years, which is a reliable track record.
CRD.B has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.9%
Div Incr Years2
Div Non Decr Years4
CRD.B Yearly Dividends per shareCRD.B Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

CRD.B pays out 45.22% of its income as dividend. This is a bit on the high side, but may be sustainable.
CRD.B's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP45.22%
EPS Next 2Y19.76%
EPS Next 3YN/A
CRD.B Yearly Income VS Free CF VS DividendCRD.B Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
CRD.B Dividend Payout.CRD.B Dividend Payout, showing the Payout Ratio.CRD.B Dividend Payout.PayoutRetained Earnings

CRAWFORD & CO -CL B

NYSE:CRD.B (6/25/2025, 8:04:00 PM)

After market: 9.83 -0.37 (-3.63%)

10.2

-0.53 (-4.94%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners26.57%
Inst Owner Change0.14%
Ins Owners67.98%
Ins Owner ChangeN/A
Market Cap504.39M
Analysts87.27
Price Target14.28 (40%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.79%
Yearly Dividend0.28
Dividend Growth(5Y)2.9%
DP45.22%
Div Incr Years2
Div Non Decr Years4
Ex-Date05-23 2025-05-23 (0.07)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.93%
Min EPS beat(2)-19.8%
Max EPS beat(2)1.94%
EPS beat(4)2
Avg EPS beat(4)0.21%
Min EPS beat(4)-19.8%
Max EPS beat(4)24.47%
EPS beat(8)4
Avg EPS beat(8)-8.22%
EPS beat(12)6
Avg EPS beat(12)-1.29%
EPS beat(16)8
Avg EPS beat(16)-1%
Revenue beat(2)1
Avg Revenue beat(2)-1.92%
Min Revenue beat(2)-5.63%
Max Revenue beat(2)1.78%
Revenue beat(4)1
Avg Revenue beat(4)-4.58%
Min Revenue beat(4)-10.09%
Max Revenue beat(4)1.78%
Revenue beat(8)1
Avg Revenue beat(8)-4.26%
Revenue beat(12)2
Avg Revenue beat(12)-2.93%
Revenue beat(16)5
Avg Revenue beat(16)-1.22%
PT rev (1m)0%
PT rev (3m)7.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.49%
Valuation
Industry RankSector Rank
PE 11.72
Fwd PE 9
P/S 0.37
P/FCF 31.37
P/OCF 8.77
P/B 3.14
P/tB N/A
EV/EBITDA 7.18
EPS(TTM)0.87
EY8.53%
EPS(NY)1.13
Fwd EY11.11%
FCF(TTM)0.33
FCFY3.19%
OCF(TTM)1.16
OCFY11.4%
SpS27.33
BVpS3.25
TBVpS-2.05
PEG (NY)0.36
PEG (5Y)2.73
Profitability
Industry RankSector Rank
ROA 3.84%
ROE 18.96%
ROCE 12.59%
ROIC 8.08%
ROICexc 9.12%
ROICexgc 21.91%
OM 4.72%
PM (TTM) 2.25%
GM 27.41%
FCFM 1.19%
ROA(3y)1.61%
ROA(5y)2.44%
ROE(3y)7.94%
ROE(5y)10.69%
ROIC(3y)7.4%
ROIC(5y)7.11%
ROICexc(3y)8.28%
ROICexc(5y)7.91%
ROICexgc(3y)19.19%
ROICexgc(5y)17.62%
ROCE(3y)11.52%
ROCE(5y)11.07%
ROICexcg growth 3Y8.36%
ROICexcg growth 5Y3.89%
ROICexc growth 3Y8.29%
ROICexc growth 5Y-1.08%
OM growth 3Y-0.78%
OM growth 5Y-6.8%
PM growth 3Y-9.71%
PM growth 5Y10.7%
GM growth 3Y2.28%
GM growth 5Y-0.53%
F-Score7
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 15.33
Debt/EBITDA 2.05
Cap/Depr 113.35%
Cap/Sales 3.07%
Interest Coverage 250
Cash Conversion 57.35%
Profit Quality 52.82%
Current Ratio 1.3
Quick Ratio 1.3
Altman-Z 3.03
F-Score7
WACC9.4%
ROIC/WACC0.86
Cap/Depr(3y)104.43%
Cap/Depr(5y)96.71%
Cap/Sales(3y)2.9%
Cap/Sales(5y)3.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.54%
EPS 3Y2.67%
EPS 5Y4.3%
EPS Q2Q%61.54%
EPS Next Y32.55%
EPS Next 2Y19.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.51%
Revenue growth 3Y5.59%
Revenue growth 5Y5.06%
Sales Q2Q%-0.33%
Revenue Next Year6.49%
Revenue Next 2Y5.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.92%
EBIT growth 3Y4.76%
EBIT growth 5Y-2.08%
EBIT Next Year71.64%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y135.87%
FCF growth 3Y-24.71%
FCF growth 5Y-28.7%
OCF growth 1Y35.48%
OCF growth 3Y-1.69%
OCF growth 5Y-7.25%